Oxymatrine Ameliorates Imiquimod-Induced Psoriasis Pruritus and Inflammation Through Inhibiting Heat Shock Protein 90 and Heat Shock Protein 60 Expression in Keratinocytes.

Xuechuan Xiang,Chuyue Tu,Qiaoyun Li,Wen Wang,Xiaoqing Huang,Zhongqiu Zhao,Hui Xiong,Zhinan Mei
DOI: https://doi.org/10.1016/j.taap.2020.115209
IF: 4.46
2020-01-01
Toxicology and Applied Pharmacology
Abstract:In this work, we aimed to investigate whether oxymatrine exerts its anti-pruritic and anti-inflammatory efficacy in the imiquimod-induced psoriasis mice and the related mechanism. We established the psoriasis model by applying the imiquimod ointment topically and oxymatrine was injected intraperitoneally as the treatment. The behavior and skin morphology results indicated that oxymatrine inhibits imiquimod-induced pruritus alleviating keratinization of skin and inflammatory infiltration. Moreover, we examined the expression of various indicators and found heat shock protein (HSP) 90 and 60 upregulated in model group, which were reversed in oxymatrine treated groups. Molecular docking and the studies in vivo confirmed that HSP90 and HSP60 participate in the inhibitory effect of oxymatrine on the phenotypes of psoriasis mice. Mechanically, immunofluorescence staining demonstrated that oxymatrine-induced downregulation of HSP90 and HSP60 was mainly in keratinocytes. In vitro results showed that oxymatrine decreases the expression of HSP90 and HSP60 upregulated by TNF-alpha and IFN-gamma in HaCaTs cells and the siRNA mediated HSP90 and HSP60 silencing reverses inflammation inhibited by oxymatrine. Taken together, these results indicate that oxymatrine relieves psoriasis pruritic and inflammation by inhibiting the expression of HSP90 and HSP60 in keratinocytes through MAPK signaling pathway
What problem does this paper attempt to address?